# New clinical trials in Philippines: 80 since Nov 2024

Updated November 4, 2026.

80 clinical studies with a site in Philippines were first posted on ClinicalTrials.gov from November 12, 2024 to November 4, 2026; 56 have an industry sponsor and 55 are recruiting or about to. The newest, NCT07915219, was posted on November 4, 2026: A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After... (Boehringer Ingelheim).

## The full list

New clinical trials with a site in Philippines: 80 rows for $5, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/country/philippines

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 80
- Industry sponsored: 56
- Recruiting or not yet: 55
- Latest posted: November 4, 2026

## Newest trials

The newest 80 of 80, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | Argentina, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| November 2, 2026 | NCT07909044 | Training, Coaching and Marketing Program for Vegetable and Fruit Vendors in Markets to Improve Food Safety Practices and Vegetable and... | The International Livestock Research Institute (ILRI) | Not applicable | Recruiting | Intake of Fruit, Intake of Vegetables, Food Safety | 1,143 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909044) |
| October 6, 2026 | NCT07861997 | ENRICH Study: A Mixed-methods Feasibility Study of a Nurse-led Model of Care for Social Frailty in Philippine Primary Care | The Hong Kong Polytechnic University | Not applicable | Not yet recruiting | Frailty, Frailty in Older Adults, Frailty in Aging | 30 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861997) |
| October 1, 2026 | NCT07851025 | Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced... | AstraZeneca | Phase 3 | Recruiting | Epithelial Ovarian Cancer | 950 | Argentina, Australia, Brazil, Bulgaria, Canada, Chile, China, Colombia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851025) |
| September 23, 2026 | NCT07837336 | An Evaluation of Nutritional Status, Body Composition, and Dietary Intakes of Filipino Pediatric Patients With Inborn Errors of... | Food and Nutrition Research Institute, Philippines | Observational | Recruiting | Metabolism, Inborn Errors, Amino Acid Metabolism, Inborn Errors | 176 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07837336) |
| September 15, 2026 | NCT07821203 | Subincisional Pockets for Sealing Clear Corneal Incisions in Cataract Surgery | Philippine Eye Research Institute | Observational | Completed | Cataract Surgery, Cataract (Post-operative Cataract Surgery Follow-up), Phacoemulsification Cataract Surgery, Wound... | 35 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07821203) |
| August 20, 2026 | NCT07775404 | A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2... | AstraZeneca | Phase 3 | Recruiting | Obesity, Overweight | 351 | China, Hong Kong, Malaysia, Philippines, Thailand | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775404) |
| August 10, 2026 | NCT07753993 | A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease. | AstraZeneca | Phase 3 | Recruiting | Chronic Kidney Disease | 7,000 | Argentina, Australia, Brazil, Bulgaria, Canada, Chile, China, Czechia, Denmark... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07753993) |
| July 31, 2026 | NCT07739420 | A Randomized, Assessor-Blinded, Intraindividual Study on the Efficacy of Fractional Carbon Dioxide Laser Versus Long-Pulsed 1064 nm Nd:YAG... | Jose R. Reyes Memorial Medical Center | Not applicable | Completed | Keratosis Pilaris (KP) | 27 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07739420) |
| July 22, 2026 | NCT07719413 | A Clinical Trial to Compare the Photoprotective Effects of Cucumber Seed Extract vs Placebo in Filipino Adults by Measurement of Minimal... | DOH - Tondo Medical Center | Not applicable | Completed | Healthy Human Volunteers With Fitzpatrick Skin Type III-V, Sunburn, Erythema | 29 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07719413) |
| July 9, 2026 | NCT07691970 | Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From... | AstraZeneca | Phase 3 | Recruiting | Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus | 1,072 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07691970) |
| June 8, 2026 | NCT07634315 | GREEN Walk: A Nature-based Gait Training to Improve the Quality of Life Among Chronic Stroke Survivors | Mariano Marcos State University | Not applicable | Completed | Chronic Stroke Survivors | 11 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07634315) |
| June 5, 2026 | NCT07630714 | A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to \< 18 Years... | AstraZeneca | Phase 2 | Recruiting | Systemic Lupus Erythematosus | 24 | Australia, Belgium, Chile, Israel, Japan, Netherlands, Peru, Philippines... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07630714) |
| June 5, 2026 | NCT07630584 | Growth, Tolerance, and Functional Biomarkers in Healthy Infants Receiving Dietary Supplements | Société des Produits Nestlé (SPN) | Not applicable | Recruiting | Healthy Infants | 327 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07630584) |
| June 3, 2026 | NCT07624305 | A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD) | AstraZeneca | Phase 3 | Recruiting | Renal Insufficiency, Chronic | 2,800 | Argentina, Austria, Brazil, Bulgaria, Canada, China, France, Germany, Greece... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07624305) |
| June 1, 2026 | NCT07617207 | Impact of the Training to Aid Patients With Stroke Program on Caregiver Knowledge, Burden, and Quality of Life | University of the Philippines Manila - Philippine General Hospital | Not applicable | Completed | Stroke, Stroke Rehabilitation, Stroke Rehabilitation and Caregivers, Quality of Life | 22 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07617207) |
| May 19, 2026 | NCT07595432 | The Purpose of This Clinical Study is to Evaluate Optimized Maximum Plus for Maximum Visual Acuity (MPMVA) Refractive Technique and Its... | Hoya Surgical Optics, Inc. | Observational | Recruiting | Visual Outcome | 140 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07595432) |
| May 19, 2026 | NCT07595042 | A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB) | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | Not yet recruiting | Tuberculosis | 900 | Argentina, Australia, Botswana, Brazil, Haiti, India, Kenya, Malawi, Mexico... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07595042) |
| May 18, 2026 | NCT07593924 | Clinical Trial of PCV13 in Infants Aged Approximately 2 Months (42 to 89 Days) | Sinovac Life Sciences Co., Ltd. | Phase 3 | Not yet recruiting | Pneumococcal Infectious Diseases | 500 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07593924) |
| May 14, 2026 | NCT07587138 | Clinical Evaluation of a Novel Trifocal IOL | Alcon Research | Not applicable | Recruiting | Aphakia, Cataract | 66 | Australia, India, Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07587138) |
| May 1, 2026 | NCT07562347 | Clinical Experience and Real-world Safety and Effectiveness of Envafolimab: Patient Access Program | IR INNOVATE RESEARCH PRIVATE LIMITED | Observational | Recruiting | Advanced Solid Tumor | 120 | Kenya, Mauritius, Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07562347) |
| April 21, 2026 | NCT07543458 | Therapeutics for Moderate and Severe Dengue | Oxford University Clinical Research Unit, Vietnam | Phase 3 | Not yet recruiting | Dengue, Severe Dengue, Mosquito-Borne Diseases, Vector Borne Diseases, Arbovirus Infections, Flavivirus Infections, RNA... | 8,800 | Bangladesh, Brazil, Colombia, Indonesia, Malaysia, Nepal, Peru, Philippines... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07543458) |
| April 20, 2026 | NCT07540793 | Evaluation of 7-day vs 1-day Packaging of Small Quantity Lipid-based Nutrition Supplementation (SQ-LNS) | University of California, San Francisco | Not applicable | Not yet recruiting | Prevention, Malnutrition, Child, Nutrition | 100 | Ethiopia, Germany, Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07540793) |
| April 16, 2026 | NCT07532863 | A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants | Novo Nordisk A/S | Observational | Recruiting | Diabetes Mellitus, Type 2 | 400 | Indonesia, Malaysia, Philippines, Singapore | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07532863) |
| March 27, 2026 | NCT07497087 | A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis | Boehringer Ingelheim | Phase 3 | Recruiting | Systemic Sclerosis | 448 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07497087) |
| March 19, 2026 | NCT07483580 | LEG-UP Feasibility Study: Elevated Leg Positioning For Acute Moderate Ischemic Stroke | Bonifacio C. Pedreogsa II | Not applicable | Completed | Acute Ischemic Stroke | 50 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07483580) |
| March 12, 2026 | NCT07468409 | JASPER™ Robotic Surgical System (Formerly Known as the ORYOM™ Robotic Surgical System) in Cataract Surgery | ForSight Robotics Ltd | Not applicable | Recruiting | Cataract | 40 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07468409) |
| March 12, 2026 | NCT07467707 | An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults | Bavarian Nordic | Phase 3 | Recruiting | Chikungunya Virus | 6,144 | Philippines, Thailand | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07467707) |
| March 9, 2026 | NCT07457060 | Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine | Sinovac Biotech Co., Ltd | Phase 4 | Recruiting | Poliomyelitis | 480 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07457060) |
| February 17, 2026 | NCT07415252 | SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years | SK Bioscience Co., Ltd. | Phase 3 | Recruiting | Varicella (Chickenpox) | 780 | Honduras, Philippines, South Korea, Thailand | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07415252) |
| February 2, 2026 | NCT07382401 | Developing Immersive Gamification Technology Systems For The Rehabilitation Management Of Adults With Parkinson's Disease (Phase 1 Trial) | Augmented eXperience E-health Laboratory | Not applicable | Not yet recruiting | Parkinson Disease, Parkinson&#39;s Disease (PD) | 30 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07382401) |
| January 14, 2026 | NCT07341477 | Efficacy of a Dietary Supplement in Infants | Société des Produits Nestlé (SPN) | Not applicable | Recruiting | Healthy Infants | 172 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07341477) |
| December 18, 2025 | NCT07291739 | A Clinical Evaluation of a Phakic Intraocular Lens | Staar Surgical Company | Not applicable | Completed | Myopia, Hyperopia, Astigmatism, Presbyopia | 47 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07291739) |
| December 11, 2025 | NCT07276724 | A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1) | Generate Biomedicines | Phase 3 | Recruiting | Severe Asthma | 786 | Brazil, Bulgaria, Chile, Czechia, Germany, Greece, Hungary, Israel, Latvia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07276724) |
| November 21, 2025 | NCT07241390 | A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney... | Eli Lilly and Company | Phase 3 | Recruiting | Atherosclerosis Cardiovascular Disease, Chronic Kidney Disease | 7,140 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07241390) |
| October 23, 2025 | NCT07220083 | A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS) | Boehringer Ingelheim | Phase 3 | Recruiting | Focal Segmental Glomerulosclerosis | 286 | Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Croatia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07220083) |
| October 14, 2025 | NCT07216703 | A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of... | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Cervical Cancer | 1,023 | Argentina, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czechia, Denmark... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07216703) |
| October 7, 2025 | NCT07211152 | Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women | Sinovac Biotech Co., Ltd | Phase 3 | Completed | Influenza | 150 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07211152) |
| October 7, 2025 | NCT07209761 | A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis | Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 3 | Recruiting | Rifampicin-Resistant Pulmonary Tuberculosis, Multidrug-Resistant Pulmonary Tuberculosis | 532 | China, Georgia, India, Indonesia, Japan, Moldova, Peru, Philippines, South... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07209761) |
| October 6, 2025 | NCT07208604 | Open Label, Multi-center, Phase I Study of TECLens Quantitative Refractive Crosslinking in Presbyopia-Aged Patients. | TECLens, Inc. | Not applicable | Not yet recruiting | Presbyopia | 25 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07208604) |
| September 19, 2025 | NCT07183423 | Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction | Makati Medical Center | Not applicable | Recruiting | Psoriasis, Atopic Dermatitis, Xerosis, Contact Dermatitis | 26 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07183423) |
| September 17, 2025 | NCT07179380 | Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With... | Insmed Incorporated | Phase 3 | Recruiting | Pulmonary Hypertension, Interstitial Lung Disease | 344 | Argentina, Australia, Austria, Belgium, Brazil, Colombia, Czechia, Denmark... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07179380) |
| September 16, 2025 | NCT07175064 | Nursing-Led Livelihood Programs and Women's Health | Angeles University Foundation | Observational | Completed | Nutrition Disorders, Stress, Psychological, Mental Health Issue | 25 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07175064) |
| September 15, 2025 | NCT07172659 | Efficacy and Safety Study of Dovramilast in People With Leprosy Type 2 Reaction | Medicines Development for Global Health | Phase 2 | Recruiting | Erythema Nodosum Leprosum | 45 | Benin, Côte d’Ivoire, Indonesia, Madagascar, Philippines, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07172659) |
| September 8, 2025 | NCT07160244 | BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies | Pfizer | Phase 3 | Recruiting | Healthy | 6,000 | Argentina, Brazil, Canada, Finland, Japan, Mexico, Netherlands, Philippines... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07160244) |
| August 21, 2025 | NCT07134595 | Comparing Conventional Continuous Ambulatory Peritoneal Dialysis Prescription (C-CAPD) With Modified-CAPD (M-CAPD) Prescription in Children... | National University Health System, Singapore | Not applicable | Recruiting | Children on Chronic Peritoneal Dialysis | 44 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07134595) |
| August 17, 2025 | NCT07127718 | Preventive Strategies for Early and Late Complications of Leptospirosis | National Kidney and Transplant Institute, Philippines | Phase 2 | Recruiting | Leptospirosis | 678 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07127718) |
| July 28, 2025 | NCT07088926 | A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis... | AstraZeneca | Phase 2 | Recruiting | Bronchiectasis With Pseudomonas Aeruginosa Colonization | 435 | Argentina, Australia, Belgium, Brazil, Canada, Chile, Denmark, France, Germany... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07088926) |
| July 24, 2025 | NCT07083596 | Efficacy of LcS-Fermented Milk on Constipation-Related Symptoms in Filipino Adults | University of Santo Tomas | Not applicable | Recruiting | Constipation, Gastrointestinal Discomfort | 60 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07083596) |
| July 14, 2025 | NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood... | Boehringer Ingelheim | Phase 3 | Recruiting | Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases | 11,800 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07064473) |
| July 14, 2025 | NCT07064161 | Efficacy of Hydrocolloid Dressing vs. Topical Antibiotic on Wound Healing of Post-Punch Biopsy Wounds | University of Santo Tomas Hospital, Philippines | Not applicable | Completed | Biopsy Wound | 60 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07064161) |
| June 29, 2025 | NCT07044297 | A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011) | Merck Sharp & Dohme LLC | Phase 3 | Active not recruiting | Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis | 4,390 | Argentina, Brazil, Chile, Colombia, Dominican Republic, France, Guatemala... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07044297) |
| June 10, 2025 | NCT07013487 | A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1) | Merck Sharp & Dohme LLC | Phase 3 | Active not recruiting | Healthy | 12,000 | Indonesia, Malaysia, Philippines, Puerto Rico, Singapore, Thailand, Vietnam | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07013487) |
| June 5, 2025 | NCT07007312 | Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML | Kura Oncology, Inc. | Phase 3 | Recruiting | Acute Myeloid Leukemia (AML) | 1,300 | Australia, Belgium, Canada, Czechia, France, Germany, Greece, Hungary, Italy... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07007312) |
| June 4, 2025 | NCT07003984 | A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children. | Bavarian Nordic | Phase 3 | Active not recruiting | Chikungunya Virus | 720 | Philippines, Puerto Rico, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07003984) |
| June 2, 2025 | NCT07000357 | A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event | AstraZeneca | Phase 3 | Recruiting | Cardiovascular Disease | 15,100 | Argentina, Brazil, Bulgaria, Canada, Chile, China, Colombia, Czechia, Denmark... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07000357) |
| May 30, 2025 | NCT06997497 | A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012) | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Colon Adenocarcinoma, Rectal Adenocarcinoma | 477 | Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Finland, France... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06997497) |
| May 23, 2025 | NCT06987474 | Capella Scientia Development Study | Alcon Research | Observational | Recruiting | Cataract | 400 | India, Philippines, Spain, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06987474) |
| May 20, 2025 | NCT06981078 | A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD | Upstream Bio Inc. | Phase 2 | Active not recruiting | Chronic Obstructive Pulmonary Disease | 666 | Argentina, Bulgaria, Chile, Czechia, Georgia, Germany, Hungary, India, Ireland... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06981078) |
| May 13, 2025 | NCT06966700 | A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms | 2,400 | Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Czechia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06966700) |
| April 27, 2025 | NCT06947499 | A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent... | LG Chem | Phase 2/3 | Active not recruiting | Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Haemophilus Influenzae Type b | 1,186 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06947499) |
| April 22, 2025 | NCT06938516 | Prospective Observational Study On The Impact Of Nebilet In Blood Pressure Control In Hypertensive Patients (HYIMPACT) | A.Menarini Asia-Pacific Holdings Pte Ltd | Observational | Recruiting | Hypertension | 4,537 | Indonesia, Malaysia, Philippines, South Korea, Taiwan, Thailand, Vietnam | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06938516) |
| April 20, 2025 | NCT06935357 | A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) | Biogen | Phase 3 | Recruiting | Immunoglobulin A Nephropathy (IgAN) | 454 | Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Colombia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06935357) |
| April 17, 2025 | NCT06932263 | Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled... | AstraZeneca | Phase 2 | Recruiting | Asthma | 540 | Argentina, Brazil, Chile, China, France, Greece, Hungary, India, Israel, Italy... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06932263) |
| April 14, 2025 | NCT06926660 | A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease | Boehringer Ingelheim | Phase 2 | Completed | Chronic Kidney Disease | 492 | Argentina, Australia, Belgium, Brazil, Canada, China, Czechia, France, Germany... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06926660) |
| March 19, 2025 | NCT06883305 | A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006) | AstraZeneca | Phase 3 | Recruiting | Chronic Obstructive Pulmonary Disease (COPD) | 990 | Brazil, Canada, Chile, China, Czechia, Denmark, Germany, India, Italy... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06883305) |
| March 12, 2025 | NCT06872892 | The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis | Boehringer Ingelheim | Phase 3 | Recruiting | Bronchiectasis | 1,755 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06872892) |
| March 6, 2025 | NCT06862661 | Enhancing Breastfeeding Self-Efficacy in Filipino Mothers: Assessing the Impact of the LactApp m-Health Tool | Angeles University Foundation | Not applicable | Completed | Breastfeeding Education | 280 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06862661) |
| March 5, 2025 | NCT06858579 | A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE) | Dianthus Therapeutics | Phase 3 | Recruiting | Chronic Inflammatory Demyelinating Polyneuropathy | 256 | Argentina, Australia, Belgium, Brazil, Bulgaria, China, Colombia, Croatia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06858579) |
| February 25, 2025 | NCT06843473 | Prevalence of Weight Related Complications Across Diverse Weight Classifications - A Large Study in India, Pakistan, Philippines and Vietnam | Novo Nordisk A/S | Observational | Completed | Obesity, Obesity-related Complications | 1,170 | India, Pakistan, Philippines, Vietnam | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06843473) |
| February 24, 2025 | NCT06841354 | A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With... | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Triple Negative Breast Neoplasms | 1,000 | Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Czechia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06841354) |
| February 13, 2025 | NCT06824181 | Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in... | Sanofi | Phase 3 | Active not recruiting | Pneumococcal Immunization | 580 | Chile, Mexico, Philippines, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06824181) |
| February 12, 2025 | NCT06823115 | Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0 | Indiana University | Observational | Enrolling by invitation | Acute Kidney Injury, Fluid Overload, Prematurity Complications, Risk Factors, Epidemiology, Chronic Kidney... | 8,000 | Argentina, Australia, Brazil, Canada, Chile, Colombia, Czechia, Denmark... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06823115) |
| January 29, 2025 | NCT06800248 | Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections | Swiss Tropical & Public Health Institute | Phase 3 | Not yet recruiting | Trichuris Trichiura; Infection, Hookworm Infection, Ascaris Lumbricoides Infection | 315 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06800248) |
| January 24, 2025 | NCT06790290 | Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy... | Inventprise Inc. | Phase 2 | Active not recruiting | Pneumococcal Disease, Invasive | 421 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06790290) |
| December 19, 2024 | NCT06742723 | A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With... | AstraZeneca | Phase 3 | Recruiting | Chronic Kidney Disease and Hypertension | 5,000 | Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06742723) |
| November 27, 2024 | NCT06708559 | Immune Health Biomarkers and Fecal Microbiota in Filipino Breastfed Infants | Société des Produits Nestlé (SPN) | Observational | Active not recruiting | Healthy | 60 | Philippines | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06708559) |
| November 26, 2024 | NCT06705478 | Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in... | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 | Suspended | Major Depressive Disorder, Mild Neurocognitive Disorder, HIV | 186 | Botswana, Brazil, India, Kenya, Malawi, Mexico, Peru, Philippines, South... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06705478) |
| November 13, 2024 | NCT06687369 | A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in... | mAbxience Research S.L. | Phase 3 | Active not recruiting | Non Squamous Non Small Cell Lung Cancer | 726 | Armenia, Bosnia and Herzegovina, Brazil, Georgia, Greece, Italy, Japan, Jordan... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06687369) |
| November 12, 2024 | NCT06684847 | A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome | argenx | Phase 3 | Active not recruiting | Primary Sjogrens Disease | 631 | Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Chile, China... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06684847) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| AstraZeneca | 11 | October 1, 2026 |
| Boehringer Ingelheim | 6 | November 4, 2026 |
| Merck Sharp & Dohme LLC | 6 | October 14, 2025 |
| Société des Produits Nestlé (SPN) | 3 | June 5, 2026 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 | May 19, 2026 |
| Alcon Research | 2 | May 14, 2026 |
| Novo Nordisk A/S | 2 | April 16, 2026 |
| Bavarian Nordic | 2 | March 12, 2026 |
| Sinovac Biotech Co., Ltd | 2 | March 9, 2026 |
| Angeles University Foundation | 2 | September 16, 2025 |
| The International Livestock Research Institute (ILRI) | 1 | November 2, 2026 |
| The Hong Kong Polytechnic University | 1 | October 6, 2026 |
| Food and Nutrition Research Institute, Philippines | 1 | September 23, 2026 |
| Philippine Eye Research Institute | 1 | September 15, 2026 |
| Jose R. Reyes Memorial Medical Center | 1 | July 31, 2026 |
| DOH - Tondo Medical Center | 1 | July 22, 2026 |
| Mariano Marcos State University | 1 | June 8, 2026 |
| University of the Philippines Manila - Philippine General Hospital | 1 | June 1, 2026 |
| Hoya Surgical Optics, Inc. | 1 | May 19, 2026 |
| Sinovac Life Sciences Co., Ltd. | 1 | May 18, 2026 |

## Conditions

| Condition group | New trials | Latest |
| --- | --- | --- |
| [Renal Insufficiency, Chronic](https://specstream.ai/data/clinical-trials/condition/renal-insufficiency-chronic) | 6 | August 10, 2026 |
| [Cataract](https://specstream.ai/data/clinical-trials/condition/cataract) | 4 | September 15, 2026 |
| [Hypertension](https://specstream.ai/data/clinical-trials/condition/hypertension) | 4 | July 14, 2025 |
| [Diabetes Mellitus, Type 2](https://specstream.ai/data/clinical-trials/condition/diabetes-mellitus-type-2) | 3 | August 20, 2026 |
| Parkinson Disease 4, Autosomal Dominant Lewy Body | 3 | October 14, 2025 |
| Bronchiectasis | 2 | November 4, 2026 |
| [Obesity](https://specstream.ai/data/clinical-trials/condition/obesity) | 2 | August 20, 2026 |
| [Stroke](https://specstream.ai/data/clinical-trials/condition/stroke) | 2 | June 1, 2026 |
| Chikungunya Fever | 2 | March 12, 2026 |
| Poliomyelitis | 2 | March 9, 2026 |
| [Myopia](https://specstream.ai/data/clinical-trials/condition/myopia) | 2 | December 18, 2025 |
| Hyperopia | 2 | December 18, 2025 |
| Presbyopia | 2 | December 18, 2025 |
| [Asthma](https://specstream.ai/data/clinical-trials/condition/asthma) | 2 | December 11, 2025 |
| [Cardiovascular Diseases](https://specstream.ai/data/clinical-trials/condition/cardiovascular-diseases) | 2 | July 14, 2025 |
| [Pulmonary Disease, Chronic Obstructive](https://specstream.ai/data/clinical-trials/condition/pulmonary-disease-chronic-obstructive) | 2 | May 20, 2025 |
| [Triple Negative Breast Neoplasms](https://specstream.ai/data/clinical-trials/condition/triple-negative-breast-neoplasms) | 2 | May 13, 2025 |
| [Frailty](https://specstream.ai/data/clinical-trials/condition/frailty) | 1 | October 6, 2026 |
| Carcinoma, Ovarian Epithelial | 1 | October 1, 2026 |
| Fallopian Tube Neoplasms | 1 | October 1, 2026 |
| Metabolism, Inborn Errors | 1 | September 23, 2026 |
| Amino Acid Metabolism, Inborn Errors | 1 | September 23, 2026 |
| [Overweight](https://specstream.ai/data/clinical-trials/condition/overweight) | 1 | August 20, 2026 |
| [Weight Loss](https://specstream.ai/data/clinical-trials/condition/weight-loss) | 1 | August 20, 2026 |
| Burnett Schwartz Berberian syndrome | 1 | July 31, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 37 | November 4, 2026 |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 20 | November 2, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 11 | September 23, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 10 | June 5, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 1 | March 9, 2026 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 1 | April 27, 2025 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).